{"id":242081,"date":"2026-08-02T21:11:00","date_gmt":"2026-08-03T02:11:00","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/08\/durvalumab-plus-chemotherapy-for-advanced-biliary-tract-cancer-a-post-hoc-analysis-of-the-topaz-1-randomized-clinical-trial"},"modified":"2026-08-02T21:11:00","modified_gmt":"2026-08-03T02:11:00","slug":"durvalumab-plus-chemotherapy-for-advanced-biliary-tract-cancer-a-post-hoc-analysis-of-the-topaz-1-randomized-clinical-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/08\/durvalumab-plus-chemotherapy-for-advanced-biliary-tract-cancer-a-post-hoc-analysis-of-the-topaz-1-randomized-clinical-trial","title":{"rendered":"Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical Trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/durvalumab-plus-chemotherapy-for-advanced-biliary-tract-cancer-a-post-hoc-analysis-of-the-topaz-1-randomized-clinical-trial.png\"><\/a><\/p>\n<p>This post hoc analysis of a phase 3 randomized clinical trial evaluates 4-year overall survival and safety of durvalumab plus gemcitabine and cisplatin in participants with advanced biliary tract cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This post hoc analysis of a phase 3 randomized clinical trial evaluates 4-year overall survival and safety of durvalumab plus gemcitabine and cisplatin in participants with advanced biliary tract cancer.<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-242081","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/242081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=242081"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/242081\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=242081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=242081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=242081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}